Aquilus Pharmaceuticals, Inc.

Winchester, MA

UEI
EM9ULMXK5F21
CAGE
5KUA2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
225 Mystic Valley Pkwy, Winchester, MA 01890, USA
Website
aquiluspharma.com
Founded
2014
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Aquilus Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Aquilus Pharmaceuticals, Inc.'s SAM.gov registration is active through May 13, 2027.

What is Aquilus Pharmaceuticals, Inc.'s most recent federal award?

Aquilus Pharmaceuticals, Inc.'s most recent federal grant award is Matrix metalloproteinase inhibitor for the treatment of ALS (W81XWH2210574), from Defense Health Agency, on June 15, 2022.

On GovTribe

See Aquilus Pharmaceuticals, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors